Regeneron Pharmaceuticals, Inc. (REGN)
Market Closed
12 Dec, 20:00
$
741. 29
-5.51
-0.74%
$
81.04B Market Cap
24.52 P/E Ratio
0% Div Yield
636,007 Volume
42.79 Eps
$ 746.8
Previous Close Day Range
734.4 746.05
Year Range
476.49 790.98
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. 3 Feb 2026 (In 1 month) | | 10.65 | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Jan 2026 (In 1 month) | | 9.26 | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Oct 2025 | | 9.67 | 11.83 |
| REGN Regeneron Pharmaceuticals, Inc. 29 Oct 2025 | | - | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Jul 2025 | | 8.53 | 12.89 |
| REGN Regeneron Pharmaceuticals, Inc. 30 Apr 2025 | | - | - |
| REGN Regeneron Pharmaceuticals, Inc. 31 Jan 2025 | | 11.38 | 12.07 |
| REGN Regeneron Pharmaceuticals, Inc. 31 Oct 2024 | | 11.69 | 12.46 |
| REGN Regeneron Pharmaceuticals, Inc. 1 Aug 2024 | | 10.61 | 11.56 |
| REGN Regeneron Pharmaceuticals, Inc. 2 May 2024 | | 10.09 | 9.55 |
| REGN Regeneron Pharmaceuticals, Inc. 2 Feb 2024 | | 10.73 | 11.86 |
| REGN Regeneron Pharmaceuticals, Inc. 2 Nov 2023 | | 10.72 | 11.59 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2016 | | 2.71 | 3.13 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Aug 2016 | | 2.65 | 2.82 |
| REGN Regeneron Pharmaceuticals, Inc. 5 May 2016 | | 2.58 | 2.57 |
| REGN Regeneron Pharmaceuticals, Inc. 9 Feb 2016 | | 3.36 | 2.83 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2015 | | 3.2 | 3.47 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Aug 2015 | | 2.77 | 2.89 |
| REGN Regeneron Pharmaceuticals, Inc. 7 May 2015 | | 2.68 | 2.88 |
| REGN Regeneron Pharmaceuticals, Inc. 10 Feb 2015 | | 2.82 | 2.79 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2014 | | 2.57 | 2.52 |
| REGN Regeneron Pharmaceuticals, Inc. 5 Aug 2014 | | 2.29 | 2.47 |
| REGN Regeneron Pharmaceuticals, Inc. 8 May 2014 | | 2.2 | 2.26 |
| REGN Regeneron Pharmaceuticals, Inc. 11 Feb 2014 | | 0.98 | 0.86 |
| REGN Regeneron Pharmaceuticals, Inc. 5 Nov 2013 | | 0.9 | 1.25 |
| REGN Regeneron Pharmaceuticals, Inc. 6 Aug 2013 | | 0.88 | 0.79 |
| REGN Regeneron Pharmaceuticals, Inc. 3 May 2013 | | 0.98 | 0.9 |
| REGN Regeneron Pharmaceuticals, Inc. 14 Feb 2013 | | 1.1 | 1.22 |
REGN Earnings Reports FAQ
What is the earnings per share (EPS) for REGN?
The current EPS is 42.79.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 20.84%, reflecting the REGN's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-01-30, based on the REGN's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 11.83 per share, reported on 2025-10-30. For dividend history, visit the REGN Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 62.66, calculated based on the most recent stock price of $741.29.
2025 © Marketlog. All Rights Reserved.
